Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Dec 24, 2024, 3:00 PM EST
Oncotelic Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 0.15 | 0.17 | 0.24 | 0.57 | 0.47 | 0.08 | Upgrade
|
| Cash & Short-Term Investments | 0.15 | 0.17 | 0.24 | 0.57 | 0.47 | 0.08 | Upgrade
|
| Cash Growth | -44.40% | -29.42% | -57.55% | 19.99% | 478.33% | 3181.18% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.02 | - | Upgrade
|
| Other Receivables | 0.02 | 0.02 | 0.02 | 0.02 | - | 0.15 | Upgrade
|
| Receivables | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.15 | Upgrade
|
| Prepaid Expenses | 0.05 | 0.06 | 0.02 | 0.02 | 0.1 | 0.04 | Upgrade
|
| Restricted Cash | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
| Total Current Assets | 0.24 | 0.27 | 0.3 | 0.63 | 0.62 | 0.27 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.01 | 0.05 | Upgrade
|
| Long-Term Investments | 22.65 | 22.65 | 22.64 | - | - | - | Upgrade
|
| Goodwill | 2.79 | 5.99 | 12.07 | 21.06 | 21.06 | 21.06 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.82 | 1.97 | 2.3 | Upgrade
|
| Long-Term Deferred Charges | 1.1 | 1.1 | 1.1 | 1.1 | - | - | Upgrade
|
| Total Assets | 26.78 | 30.01 | 36.12 | 23.61 | 23.66 | 23.68 | Upgrade
|
| Accounts Payable | 1.69 | 1.66 | 1.74 | 1.93 | 1.94 | 1.79 | Upgrade
|
| Accrued Expenses | 1.12 | 1.12 | 1.11 | 1.57 | 1.19 | 0.86 | Upgrade
|
| Short-Term Debt | 10.64 | 10.68 | 11.26 | 8.99 | 4.65 | 0.96 | Upgrade
|
| Other Current Liabilities | 2.91 | 3.05 | 2.82 | 2.97 | 3.4 | 3.17 | Upgrade
|
| Total Current Liabilities | 16.36 | 16.5 | 16.92 | 15.45 | 11.18 | 6.78 | Upgrade
|
| Long-Term Debt | 2.29 | 1.9 | - | - | - | - | Upgrade
|
| Total Liabilities | 18.65 | 18.4 | 16.92 | 15.45 | 11.18 | 6.78 | Upgrade
|
| Common Stock | 4.07 | 3.99 | 3.92 | 3.75 | 0.91 | 0.84 | Upgrade
|
| Additional Paid-In Capital | 42.22 | 41.66 | 41.42 | 35.22 | 32.49 | 28.19 | Upgrade
|
| Retained Earnings | -37.44 | -33.52 | -25.93 | -31.02 | -21.63 | -12.13 | Upgrade
|
| Total Common Equity | 8.85 | 12.13 | 19.41 | 7.96 | 11.77 | 16.9 | Upgrade
|
| Minority Interest | -0.72 | -0.52 | -0.22 | 0.2 | 0.71 | - | Upgrade
|
| Shareholders' Equity | 8.13 | 11.61 | 19.19 | 8.16 | 12.48 | 16.9 | Upgrade
|
| Total Liabilities & Equity | 26.78 | 30.01 | 36.12 | 23.61 | 23.66 | 23.68 | Upgrade
|
| Total Debt | 12.94 | 12.57 | 11.26 | 8.99 | 4.65 | 0.96 | Upgrade
|
| Net Cash (Debt) | -12.79 | -12.4 | -11.02 | -8.42 | -4.18 | -0.88 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.03 | -0.02 | -0.03 | -0.05 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 407.29 | 399.68 | 392.87 | 378.63 | 91.26 | 87.01 | Upgrade
|
| Total Common Shares Outstanding | 407.29 | 399.18 | 391.85 | 375.29 | 90.6 | 84.07 | Upgrade
|
| Working Capital | -16.12 | -16.23 | -16.62 | -14.83 | -10.57 | -6.51 | Upgrade
|
| Book Value Per Share | 0.02 | 0.03 | 0.05 | 0.02 | 0.13 | 0.20 | Upgrade
|
| Tangible Book Value | 6.06 | 6.14 | 7.34 | -13.93 | -11.27 | -6.47 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.02 | 0.02 | -0.04 | -0.12 | -0.08 | Upgrade
|
| Machinery | - | - | - | - | - | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.